Femtech Market Size & Share 2025 – 2034

Femtech Market Size

The global femtech market was estimated at USD 60.2 billion in 2024 and is expected to grow at a CAGR of 16% during 2025 to 2034. Femtech is also known as female technology, is a segment dedicated to developing technologies, products, and services specifically focusing on women’s health needs. This includes advances in reproductive health, fertility, pregnancy, menopause, menstrual health apps, sexual wellness, and general healthcare for women. The aim of femtech is to bridge gaps in women’s healthcare by offering more targeted, personalized, and accessible solutions through technology.
 

The global femtech market is experiencing significant growth due to rising usage of digital technology to manage women health in developed countries. Women in developed countries are more comfortable in using technology in their daily lives, including digital health platforms. This has led to more women adopting health apps and wearables, contributing to the growing demand for femtech solutions. Additionally, 33% used wearable devices, and 18.7% shared health information, showing the integration of digital health tools, especially among women with chronic conditions.
 

Additionally, the increasing prevalence of chronic conditions such as cancer, diabetes, hypertension, and mental health disorders, are major catalyst for the market growth. Thus, femtech offers personalized and targeted tools to manage these complicated issues, highlighting the need for advanced technology in addressing significant health concerns.
 

Femtech Market Trends

• The growing investment in the femtech industry is highlighting a significant shift towards prioritizing women’s health through advanced solutions, with the area receiving considerable financial support and experiencing prominent market growth in recent years.
   
• Further, the growing investment in femtech is due to the strong healthcare infrastructure in developing countries. This involves advanced research in women’s health, well established insurance systems, and increasing government funding for digital health innovations.
   
• For example, according to a report from Statista, in 2022, U.S. led the global femtech investments with over USD 11.2 billion, followed by Israel with USD 1.3 billion of investments. These substantial investments are proof that the growing potential of femtech to transform women’s health services globally.
   
• Additionally, governments and regulatory bodies are promoting a conductive environment for femtech innovation. For instance, the European Commission’s Horizon Europe program, with a USD 106.7 billion budget for 2021 – 2027, is dedicated to advancing women’s health technologies and digital health solutions.
   
• Moreover, established healthcare companies are increasingly chasing partnerships and acquisitions within the femtech space. This trend reflects a strategic effort to increase product portfolios and capitalize on rising market opportunities, further supporting the sector and attracting additional investment, which escalates the growth of the market.
   

Femtech Market Analysis

Based on type, the global femtech industry was estimated at USD 60.2 billion in 2024. The product segment held revenue of USD 11.5 billion in 2024 and the segment is poised for significant growth rate of 13.8% during 2025 to 2034.
 

• Rising awareness of women’s pregnancy related issues, innovations in wearable and mobile health technologies, and growing demand for personalized healthcare solutions are driving the growth of the market.
   
• For instance, data from a 2023 National Population Register (NPR) indicates that nearly 800 women died each day from pregnancy or childbirth-related issues, associating to approximately one death every two minutes.
   
• Further, the increasing technological advancements, such as the development of advanced wearable devices and mobile applications, are accelerating real-time health monitoring and management for women.
   
• For example, Ava fertility has launched a clinically tested wearable bracelet that tracks various physiological parameters such as skin temperature, sleep, physiological stress, and resting pulse rate and others, to predict women’s fertile window in real time.
   
• Additionally, the growing participation of women in clinical trials and research, along with the new innovations such as artificial intelligence in healthcare and data analytics, has engaged to a substantial improvements in new product development and establishing femtech as a prominent player in the digital healthcare sector.
   

Based on application, the femtech market is segmented into pregnancy and nursing care, reproductive health, pelvic and uterine healthcare, general healthcare and wellness, and other applications. The reproductive health segment accounted for a revenue share of 43.9% and with revenue of USD 26.4 billion in 2024.
 

• The growing awareness of women’s health issues, such as fertility, menstruation, pregnancy, and menopause, has significantly risen due to social programs and educational campaigns, escalating demand for specialized reproductive health solutions. This increased awareness has initiated a more informed consumer base actively seeking reproductive health products and services.
   
• Additionally, the reduction of social stigma of menstruation, fertility, and menopause has facilitated a more open discussions related to this issues, has escalated the demand for related products. For instance, a study published in the Lancet Regional Health that in 2022, U.S. found that 64% of women felt more comfortable about discussing menstruation compared to five years ago.
   
• Further, advancement in technology have transformed reproductive health monitoring. Innovations in wearable devices, mobile applications, telemedicine, have introduced new methods for tracking and improving reproductive health, which helps to accelerate the market growth.
   

Based on end use, the femtech market is segmented into direct-to-consumer, hospitals, fertility clinics, surgical centers, diagnostic centers, and other end-users. The direct-to-consumer segment held the largest revenue of USD 19.5 billion in 2024.
 

• The market is experiencing a significant growth, driven by consumers seeking products designed to their specific healthcare needs. Femtech companies are providing customized solutions for menstrual health, menopause, fertility via direct-to-consumers channels. These companies utilize user data to upgrade and personalize their offerings, enhancing product efficacy and consumers satisfaction.
   
• For instance, in 2024 U.S. based women’s health startup ELANZA Wellness launched its initiative through its newly established endometriosis care division. The Endo app is designed to assist women with endometriosis in managing their symptoms from their home. It offers personalized recommendations, therapeutic classes and educational resources while facilitating virtual connections with support of networks and healthcare providers.
   
• Moreover, direct to consumer model provides a convenient shopping experience for women, to access the femtech products from their home only. This is particularly benefited for products related to sensitive health issues or those products require privacy. Thus, this escalated the demand for femtech products and also accelerated the market growth.
   

North America femtech market accounted for USD 19.5 billion revenues in 2024 and is predicted to witness substantial market growth over the analysis timeline. The U.S. market dominated the region with a revenue share of 89.2% in 2024.
 

• The U.S. has a growing focus on women health issues, which is boosting the demand for femtech solutions. Women are increasingly seeking personalized, accessible, and efficient healthcare options. For instance, according to the survey conducted by the Kaiser Family Foundation, 38% of women reported delaying or forgoing healthcare due to its cost, thus this highlights the need for more accessible and affordable solutions for women.
   
• Further, supportive regulatory environments and growing focus on women’s health policies are  promoting new innovations and market growth. The U.S. regulatory frameworks are stimulating the safe and effective use of femtech products which contribute to market growth.
   
• For instance, the FDA’s Digital Health Center of Excellence, established in 2020, aims to advance digital health technology, including innovations in women’s health, by providing regulatory advice and support to innovators.
   

Europe: The femtech market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The UK's advanced digital infrastructure and widespread adoption of mobile technology are significantly enhancing access to femtech products and services, particularly through telehealth platforms and health applications.
   
• The rising incidence of chronic disorders such as cancer, diabetes, hypertension, and mental health disorders are on rise in the UK., accelerating the demand for the femtech solutions.
   
• Additionally, many femtech service providers collaborate with national health services (NHS) and private healthcare to enhance access to women’s health solutions which includes fertility, pregnancy, and menopause care. these collaborations leads to credibility to apps and gain user trust.
   

Asia Pacific: Japan femtech market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Through programs such the ‘Health Japan 21’ campaign, which promotes preventive healthcare, the Japanese government is raising awareness of women’s health needs, promoting the adoption of femtech solutions for menstrual health, fertility tracking and menopause management.
   
• Moreover, growing awareness and acceptance of women’s health issues are rising in Japan. As societal attitudes develop, there is a greater openness toward discussing and addressing women’s health needs, leading to the growing adoption of femtech solutions.
   

Middle East and Africa: The femtech market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• The rise in women’s health awareness programs in Saudi Arabia that focuses on preventive care and treatment for conditions such as menopause, maternal health, fertility related issues.
   
• Thus, femtech apps play key role in promoting the early interventions and reproductive health education and lifestyle modifications, helping users to prevent chronic issues and enhance overall well-being.
   

Femtech Market Share

The top 4 players of the femtech industry account for approximately 40% of the market share which includes companies such as Elvie, BioWink GmbH, Univfy, Sera Prognostics, and, among others. Moreover, strategic partnerships with OB-GYN clinics, fertility centers, research institutes, and government agencies play a primary role in advancing the development of products and getting the necessary permits. The development of public awareness through the social media platform and digital health campaigns will encourage more individuals to adopt the femtech solutions, enabling market players to strengthen their position in this growing sector.
 

Femtech Market Companies

Some of the eminent market participants operating in the femtech industry include:

• BioWink GmbH
• Athena Feminine Technologies
• Conceivable, Inc
• HeraMED
• Elvie
• iSono Health
• Nuvo Cares
• Minerva Surgical
• Prelude
• Sustain Natural
• Sera Prognostics
• Univfy
• Totohealth
   
• BioWink GmbH has strong digital health platform, driving extensive adoption of menstrual and fertility tracking solutions. The Company’s clue App leverages predictions and cycle insights, ensuring accurate and personalized reproductive health management.
   
• Sera Prognostics specializes in early pregnancy risk assessment, enhancing maternal -fetal care through its PreTRM Test.
   

Femtech Industry News:

• In June 2024, HeraMED limited announced the launched of HeraCARE within the Telstra Health Smart Connected Care Ecosystem. HeraCAREis the first remote maternity solution. This partnership aided HeraCARE by expanding its accessibility in the healthcare industry.
   
• In March 2021, BioWink announced the FDA approval of Clue Birth control, a digital contraceptive integrated within the Clue period-tracking app. This approval enhanced the company’s market presence by providing a new innovative solutions to the consumers and also expanding its product portfolio.
   

The femtech market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Type

• Products
• Software
• Services

Market, By Application

• Reproductive health
  • Menstrual cycle and fertility
  • Menopause
• Pregnancy and nursing care
• Pelvic and uterine healthcare
• General healthcare and wellness
• Other applications

Market, By End Use

• Direct-to-consumer
• Hospitals
• Fertility clinics
• Surgical centers
• Diagnostic centers
• Other end-users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
• Latin America 
  • Brazil
  • Mexico
• Middle East and Africa 
  • South Africa
  • Saudi Arabia